Common polymorphisms of CYP2C19 and CYP2C9 affect the pharmacokinetic and pharmacodynamic response to clopidogrel but not prasugrel

収録刊行物

• J Thromb Haemost

  J Thromb Haemost 5 2429-2436, 2007